Research outputs
2026
Host adaptation and genome evolution of the broad host range fungal rust pathogen, Austropuccinia psidii.
Luo, Z., Tobias, P. A., Singh, L., Dong, C., Martino, A. M., Saber, E., . . . Boufleur, T. R. (2026). Host adaptation and genome evolution of the broad host range fungal rust pathogen, Austropuccinia psidii.. G3 (Bethesda, Md.), 16(1), jkaf255. doi:10.1093/g3journal/jkaf255
Effectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT
Flohr, C., Chan, K., Ahmed, A., Ashoor, F., Beattie, P. E., Browne, F., . . . Irvine, A. D. (2026). Effectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin for severe childhood atopic dermatitis: a synopsis of the TREAT RCT. Efficacy and Mechanism Evaluation, 1-49. doi:10.3310/ahdr8524
2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis.
Ramanan, A. V., Dick, A. D., Jaki, T., Caruso, G., Robertson, D. S., Jones, A. P., . . . Beresford, M. W. (2025). Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis.. Pediatric rheumatology online journal, 23(1), 55. doi:10.1186/s12969-025-01107-1
Methotrexate and ciclosporin both reduce levels of circulating interleukin (IL)-4 and IL-13 expressing CD4+ memory T cells in childhood atopic dermatitis.
Olsson, A., Steel, K., Cooper, R., Jones, A. P., Chan, K. R., Ogg, G., . . . Taams, L. S. (2025). Methotrexate and ciclosporin both reduce levels of circulating interleukin (IL)-4 and IL-13 expressing CD4+ memory T cells in childhood atopic dermatitis.. Clinical and experimental dermatology, 50(11), 2249-2254. doi:10.1093/ced/llaf301
S5 HAP-FAST: a pilot sequential multiple assignment randomised trial (SMART) comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia plus panel in adults with suspected non-ventilator-associated hospital-acquired pneumonia
Wootton, D., Powell, I., Willshaw, S., Tao, A., Shafiqa, N., Adegbenro, E., . . . Jones, A. (2025). S5 HAP-FAST: a pilot sequential multiple assignment randomised trial (SMART) comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia plus panel in adults with suspected non-ventilator-associated hospital-acquired pneumonia. In Emerging clinical trial data (pp. A9.2-A10). BMJ Publishing Group Ltd and British Thoracic Society. doi:10.1136/thorax-2025-btsabstracts.11
Salt warning labels as a public health policy in the out-of-home food sector: online and real-world randomised controlled trials
Evans, R., Brealey, J., Clarke, N., Falbe, J., Finlay, A., Jones, A., . . . Robinson, E. (2025). Salt warning labels as a public health policy in the out-of-home food sector: online and real-world randomised controlled trials. Appetite, 213, 108080. doi:10.1016/j.appet.2025.108080
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: a secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT).
Wan, M., Jones, A. P., Maskrey, D., Arenas-Hernandez, M., Rosala-Hallas, A., Beattie, P. E., . . . Flohr, C. (2025). Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: a secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT).. Clinical and experimental dermatology, 50(8), 1623-1627. doi:10.1093/ced/llaf147
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation.
Sach, T. H., Chan, K. R., Jones, A. P., Rosala-Hallas, A., Spowart, C., Ashoor, F., . . . Flohr, C. (2025). Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation.. The British journal of dermatology, 192(2), 349-350. doi:10.1093/bjd/ljae363
Methotrexate versus Ciclosporin in the Treatment of Severe Atopic Eczema in Children: An economic evaluation
Sach, T. H., Jones, A., Rosala-Hallas, A., Spowart, C., Ashoor, F., Irvine, A. D., . . . Flohr, C. (2025). Methotrexate versus Ciclosporin in the Treatment of Severe Atopic Eczema in Children: An economic evaluation.
2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK.
Humphries, C., Addison, M., Aithal, G., Boyd, J., Briody, L., Campbell, J. D. M., . . . Dear, J. W. (2024). Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK.. BMJ open, 14(12), e089417. doi:10.1136/bmjopen-2024-089417
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.
Bruce, G., Rosala-Hallas, A., Jones, A. P., Jones, A. P., Turner, C., Dalton, N., . . . Flohr, C. (2024). The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.. The British journal of dermatology, 191(5), 851-852. doi:10.1093/bjd/ljae276
The effect of stealth vs. declared reductions to lunch meal portion size on subsequent energy intake: A randomised control experiment.
Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction.
Pain, O., Jones, A., Al Khleifat, A., Agarwal, D., Hramyka, D., Karoui, H., . . . Al-Chalabi, A. (2024). Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction.. Heliyon, 10(15), e35342. doi:10.1016/j.heliyon.2024.e35342
HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.
Shafiqa, N., Aston, S., Howard, A., Turtle, L., Abrams, S., Young, B., . . . Wootton, D. G. (2024). HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.. BMJ open, 14(7), e088490. doi:10.1136/bmjopen-2024-088490
Macrophage Therapy for Acute Liver Injury (MAIL): a Phase 1 Randomised, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Activity of Allogeneic Alternatively Activated Macrophages in Patients with Paracetamol-induced Acute Liver Injury
Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.
Deja, E., Donohue, C., Semple, M. G., Woolfall, K., & BESS Investigators. (2024). Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.. BMJ open, 14(1), e077023. doi:10.1136/bmjopen-2023-077023
2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Flohr, C., Rosala-Hallas, A., Jones, A. P., Beattie, P., Baron, S., Browne, F., . . . TREAT Trial Investigators. (2023). Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.. The British journal of dermatology, 189(6), 674-684. doi:10.1093/bjd/ljad281
2022
Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop
Rosala-Hallas, A., Jones, A. P., Williamson, P. R., Bedson, E., Compton, V., Fernandes, R. M., . . . McNamara, P. S. (2022). Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop. BMJ Open, 12(3), e052943. doi:10.1136/bmjopen-2021-052943
Assembly and Annotation of Escherichia coli Bacteriophage U115.
An, W., Emsbo, C., Frey, E., Hu, V., Jones, A., Latif, N., . . . Burmeister, A. R. (2022). Assembly and Annotation of Escherichia coli Bacteriophage U115.. Microbiology resource announcements, 11(2), e0094921. doi:10.1128/mra.00949-21
Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.
McNamara, P. S., Clayton, D., Burchett, C., Compton, V., Peak, M., Clark, J., & Jones, A. P. (2022). Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.. PloS one, 17(2), e0263044. doi:10.1371/journal.pone.0263044
2021
Weight-based discrimination in financial reward and punishment decision making: causal evidence using a novel experimental paradigm
Energy labelling of alcoholic drinks as a public health policy to reduce obesity: An integrative review
“Drinkers Like Me”: a thematic analysis of comments responding to an online article about moderating alcohol consumption
Irizar, P., Puddephatt, J. -A., Warren, J., Field, M., Jones, A., Rose, A., . . . goodwin, L. (2021). “Drinkers Like Me”: a thematic analysis of comments responding to an online article about moderating alcohol consumption. doi:10.31234/osf.io/6ygn7
A change of scenery: Does exposure to images of nature affect delay discounting and food desirability?
Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus process
Gale, C., Dorling, J., Arch, B., Woolfall, K., Deja, E., Roper, L., . . . Tume, L. (2021). Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus process. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 106(3), F292-F297. doi:10.1136/archdischild-2020-319469
Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol
Setiabudi, W., Hungerford, D., Subramaniam, K., Vaselli, N. M., Shaw, V. E., Wilton, M., . . . French, N. (2021). Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open, 11(3), e048317. doi:10.1136/bmjopen-2020-048317
Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (2021). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials. F1000Research, 9, 323. doi:10.12688/f1000research.23316.3
P0080 / #320: IS A TRIAL OF NO ROUTINE GASTRIC RESIDUAL VOLUME MONITORING TO GUIDE ENTERAL FEEDING IS POSSIBLE IN UK PICUS AND NICUS?
Tume, L., Valla, F., Gale, C., Arch, B., Pathan, N., Latten, L., . . . Dorling, J. (2021). P0080 / #320: IS A TRIAL OF NO ROUTINE GASTRIC RESIDUAL VOLUME MONITORING TO GUIDE ENTERAL FEEDING IS POSSIBLE IN UK PICUS AND NICUS?. Pediatric Critical Care Medicine, 22(Supplement 1 3S), 73. doi:10.1097/01.pcc.0000738664.95044.d8
Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill Children
Tume, L. N., Arch, B., Woolfall, K., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (2020). Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill Children. Journal of Parenteral and Enteral Nutrition. doi:10.1002/jpen.1817
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Williamson, P. R. (2021). Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT. HEALTH TECHNOLOGY ASSESSMENT, 25(65), 1-+. doi:10.3310/hta25650
2020
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020)
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020). SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-61783-9
National survey of feasibility of NIV trials for management of children with bronchiolitis.
Rosala-Hallas, A., Jones, A. P., Bedson, E., Compton, V., Fernandes, R. M., Lacy, D., . . . McNamara, P. S. (2020). National survey of feasibility of NIV trials for management of children with bronchiolitis.. BMJ Paediatrics Open, 4(1), e000780. doi:10.1136/bmjpo-2020-000780
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Grp, T. O. R. P. E. D. O. -C. F. S. (2020). Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial. LANCET RESPIRATORY MEDICINE, 8(10), 975-986. doi:10.1016/S2213-2600(20)30331-3
The psychology of obesity: An umbrella review and evidence-based map of the psychological correlates of heavier body weight
Identification of Behavior Change Techniques From Successful Web-Based Interventions Targeting Alcohol Consumption, Binge Eating, and Gambling: Systematic Review (Preprint)
Humphreys, G., Evans, R., Makin, H., Cooke, R., & Jones, A. (2020). Identification of Behavior Change Techniques From Successful Web-Based Interventions Targeting Alcohol Consumption, Binge Eating, and Gambling: Systematic Review (Preprint). doi:10.2196/preprints.22694
Examining Cognitive Bias Modification interventions for reducing food value and choice: Two pre-registered, online studies.
Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 2]
McKay, A., Jones, A., Gamble, C., Farmer, A., & Williamson, P. (2020). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 2]. F1000Research. doi:10.12688/f1000research.23316.2
Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 1]
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (2020). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 1]. F1000Research, 9. doi:10.12688/f1000research.23316.1
Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study
Tume, L. N., Woolfall, K., Arch, B., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (2020). Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study. HEALTH TECHNOLOGY ASSESSMENT, 24(23), 1-+. doi:10.3310/hta24230
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Ramanan, A. V., Dick, A. D., Guly, C., McKay, A., Jones, A. P., Hardwick, B., . . . APTITUDE Trial Management Group. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology, 2(3), e135-e141. doi:10.1016/s2665-9913(20)30008-4
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.. Scientific reports, 10(1). doi:10.1038/s41598-020-58790-1
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
Jones, A. P., Clayton, D., Nkhoma, G., Sherratt, F. C., Peak, M., Stones, S. R., . . . Baildam, E. M. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.. Health Technology Assessment, 24(36), 1-152. doi:10.3310/hta24360
2019
P05 A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK
Jones, A., Clayton, D., Nkhoma, G., Sherratt, F., Peak, M., Ramanan, A., . . . Baildam, E. (2019). P05 A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK. Rheumatology, 58(Supplement_4). doi:10.1093/rheumatology/kez415.002
P07 Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals
Stones, S. R., Bagley, H., Beresford, M. W., Jones, A., McErlane, F., Moitt, T., . . . Baildam, E. M. (2019). P07 Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals. Rheumatology, 58(Supplement_4). doi:10.1093/rheumatology/kez415.003
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
Horton, S., Jones, A. P., Guly, C. M., Hardwick, B., Beresford, M. W., Lee, R. W. J., . . . Ramanan, A. V. (2019). Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.. American journal of ophthalmology. doi:10.1016/j.ajo.2019.06.007
A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK
Baildam, E., Jones, A., Clayton, D., Nkoma, G., Peak, M., Ramanan, A., . . . Beresford, M. (2019). A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934). doi:10.1136/annrheumdis-2019-eular.6751
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., . . . Beresford, M. W. (2019). Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14(6). doi:10.1371/journal.pone.0215739
IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS
Stones, S., Bagley, H., Jones, A., Mcerlane, F., Moitt, T., Nkhoma, G., . . . Baildam, E. (2019). IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934-1935). doi:10.1136/annrheumdis-2019-eular.1799
WS01-1 Effectiveness of IV compared to oral eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: multicentre randomised controlled trial (TORPEDO-CF)
Langton Hewer, S. C., Smyth, A. R., Jones, A. P., Brown, M., Hickey, H., Williamson, P. R., . . . Ashby, D. (2019). WS01-1 Effectiveness of IV compared to oral eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: multicentre randomised controlled trial (TORPEDO-CF). Journal of Cystic Fibrosis, 18, S1. doi:10.1016/s1569-1993(19)30117-1
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., . . . Ramanan, A. V. (2019). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology, 126(3), 415-424. doi:10.1016/j.ophtha.2018.09.043
2018
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)
Irvine, A. D., Jones, A. P., Beattie, P., Baron, S., Browne, F., Ashoor, F., . . . Flohr, C. (2018). A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). BRITISH JOURNAL OF DERMATOLOGY, 179(6), 1297-1306. doi:10.1111/bjd.16717
Abstracts.
Irvine, A. D., Jones, A. P., Beattie, P., Baron, S., Browne, F., Ashoor, F., . . . TREAT Trial Investigators. (2018). Abstracts. . The British journal of dermatology, 179(6), e232-e262. doi:10.1111/bjd.17052
Interventions for helping people recognise early signs of recurrence in depression
Morriss, R. K., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2018). Interventions for helping people recognise early signs of recurrence in depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd004855.pub2
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Compton, V., Peak, M., Grice, J., Clark, J., Lee, L., Burchett, C., . . . McNamara, P. (2018). Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX). In EUROPEAN RESPIRATORY JOURNAL Vol. 52. doi:10.1183/13993003.congress-2018.OA341
Stage of prolonged survival in ALS - Author's reply.
Al-Chalabi, A., Fang, T., Khleifat, A. A., Meurgey, J. -H., Jones, A., Leigh, P. N., & Bensimon, G. (2018). Stage of prolonged survival in ALS - Author's reply.. The Lancet. Neurology, 17(7), 579-580. doi:10.1016/s1474-4422(18)30208-4
Stage of prolonged survival in ALS.
Brooks, B. R., Bravver, E. K., Langford, V. L., Bockenek, W. L., & Lindblom, S. S. (2018). Stage of prolonged survival in ALS.. The Lancet. Neurology, 17(7), 579. doi:10.1016/s1474-4422(18)30207-2
Failed attempts to improve the reliability of the Alcohol Visual Probe task following empirical recommendations
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Ramanan, A. V., Dick, A. D., Jones, A. P., Guly, C., Hardwick, B., Hickey, H., . . . Beresford, M. W. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC RHEUMATOLOGY, 2(1). doi:10.1186/s41927-018-0010-2
2017
63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa
Hewer, S. L., Hickey, H., Jones, A., Blundell, M., & Smyth, A. R. (2017). 63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa. Journal of Cystic Fibrosis, 16, S80. doi:10.1016/s1569-1993(17)30428-9
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160
Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt, S. J., Jones, A. P., & Howard, J. (2017). Hydroxyurea (hydroxycarbamide) for sickle cell disease.. The Cochrane database of systematic reviews, 4, CD002202. doi:10.1002/14651858.cd002202.pub2
<i>ATXN2</i> trinucleotide repeat length correlates with risk of ALS
Sproviero, W., Shatunov, A., Stahl, D., Shoai, M., van Rheenen, W., Jones, A. R., . . . Al-Chalabi, A. (2017). <i>ATXN2</i> trinucleotide repeat length correlates with risk of ALS. NEUROBIOLOGY OF AGING, 51. doi:10.1016/j.neurobiolaging.2016.11.010
2016
Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients.
Benigni, M., Ricci, C., Jones, A. R., Giannini, F., Al-Chalabi, A., & Battistini, S. (2016). Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients.. Neuromolecular medicine, 18(4), 551-560. doi:10.1007/s12017-016-8396-8
Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.
Altowati, M. A., Jones, A. P., Hickey, H., Williamson, P. R., Barakat, F. M., Plaatjies, N. C., . . . Sanderson, I. R. (2016). Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.. Pilot and feasibility studies, 2, 71. doi:10.1186/s40814-016-0112-9
ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2016). ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 264-265). doi:10.1136/annrheumdis-2016-eular.6053
2015
Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencing.
Graves, C. A., Jones, A., Reynolds, J., Stuart, J., Pirisi, L., Botrous, P., & Wells, J. (2015). Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencing.. Neuroendocrinology, 101(2), 112-119. doi:10.1159/000370310
2014
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
Smith, C. T., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit. TRIALS, 15. doi:10.1186/1745-6215-15-127
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis
Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . The SYCAMORE Trial Management Group. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials, 15. doi:10.1186/1745-6215-15-14
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.
Tudur Smith, C., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.. Trials, 16(15), 127.
2013
The role of anticipation in drug addiction and reward
Jędras, P., Jones, A., & Field, M. (2013). The role of anticipation in drug addiction and reward. Neuroscience and Neuroeconomics, Volume 3, 1-10. doi:10.2147/nan.s35917
Genetic ablation of phospholipase C delta 1 increases survival in SOD1<SUP>G93A</SUP> mice
Staats, K. A., Van Helleputte, L., Jones, A. R., Bento-Abreu, A., Van Hoecke, A., Shatunov, A., . . . Van Den Bosch, L. (2013). Genetic ablation of phospholipase C delta 1 increases survival in SOD1<SUP>G93A</SUP> mice. NEUROBIOLOGY OF DISEASE, 60, 11-17. doi:10.1016/j.nbd.2013.08.006
Fluctuating disinhibition: implications for the understanding and treatment of alcohol and other substance use disorders.
Jones, A., Christiansen, P., Nederkoorn, C., Houben, K., & Field, M. (2013). Fluctuating disinhibition: implications for the understanding and treatment of alcohol and other substance use disorders.. Frontiers in psychiatry, 4, 140. doi:10.3389/fpsyt.2013.00140
Effects of Alcohol Cues on Craving and Ad Libitum Alcohol Consumption in Social Drinkers: The Role of Disinhibition
Jones, A., Rose, A. K., Cole, J., & Field, M. (2013). Effects of Alcohol Cues on Craving and Ad Libitum Alcohol Consumption in Social Drinkers: The Role of Disinhibition. JOURNAL OF EXPERIMENTAL PSYCHOPATHOLOGY, 4(3), 239-249. doi:10.5127/jep.031912
P300 during response inhibition is associated with ad-lib alcohol consumption in social drinkers
Jones, A., Field, M., Christiansen, P., & Stancak, A. (2013). P300 during response inhibition is associated with ad-lib alcohol consumption in social drinkers. JOURNAL OF PSYCHOPHARMACOLOGY, 27(6), 507-514. doi:10.1177/0269881113485142
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials
Jones, A. P., Conroy, E., Williamson, P. R., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. BMC MEDICAL RESEARCH METHODOLOGY, 13. doi:10.1186/1471-2288-13-50
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials
Jones, A., Conroy, E., Williamson, P., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. In Trials Vol. 14 (pp. O92). doi:10.1186/1745-6215-14-s1-o92
The use of systematic reviews in the planning,design and condut of randomised trials
Jones, A. P. (2013). The use of systematic reviews in the planning,design and condut of randomised trials [Public Performance].
2012
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BRITISH MEDICAL JOURNAL, 345. doi:10.1136/bmj.e6664
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ, 345(nov05 1), e6664. doi:10.1136/bmj.e6664
Reduced anterior cingulate cortex activity during response inhibition is associated with ad-lib alcohol consumption
JONES, A., FIELD, M., CHRISTIANSEN, P., & STANCAK, A. (2012). Reduced anterior cingulate cortex activity during response inhibition is associated with ad-lib alcohol consumption. Appetite, 59(2), 629. doi:10.1016/j.appet.2012.05.076
Reward expectancy promotes generalised increases in attentional bias for rewarding stimuli
JONES, A., HOGARTH, L., CHRISTIANSEN, P., ROSE, A., MARTINOVIC, J., & FIELD, M. (2012). Reward expectancy promotes generalised increases in attentional bias for rewarding stimuli. Appetite, 59(2), 629. doi:10.1016/j.appet.2012.05.077
The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS). HEALTH TECHNOLOGY ASSESSMENT, 16(40), 1-+. doi:10.3310/hta16400
The genetics and neuropathology of amyotrophic lateral sclerosis.
Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., & van den Berg, L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis.. Acta neuropathologica, 124(3), 339-352. doi:10.1007/s00401-012-1022-4
The effect of restraint beliefs on alcohol-seeking behavior.
Jones, A., Cole, J., Goudie, A., & Field, M. (2012). The effect of restraint beliefs on alcohol-seeking behavior.. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 26(2), 325-329. doi:10.1037/a0025546
Exploring mediators of food insecurity and obesity: a review of recent literature.
Franklin, B., Jones, A., Love, D., Puckett, S., Macklin, J., & White-Means, S. (2012). Exploring mediators of food insecurity and obesity: a review of recent literature.. Journal of community health, 37(1), 253-264. doi:10.1007/s10900-011-9420-4
The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS). HTA, 16(40).
2011
The use of the 5-year-olds' index: comparison between study models and intraoral photographs.
McAuliffe, N. J., Jones, A. P., Cumberbirch, V. C., & Russell, J. I. (2011). The use of the 5-year-olds' index: comparison between study models and intraoral photographs.. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 48(5), 526-531. doi:10.1597/09-265
The use of Systematic reviews in the design of randomised controlled trials
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In MRC North West Hub for Trials Methodology Research 'Showcase Meeting' Vol. -. Liverpool: -.
The use of Systematic reviews in the design of randomised controlled trials
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In Clinical Trials Methodology conference Vol. -. -: MRC Network of HUBS for trials methodology Research.
The use of systematic reviews in the design of randomised trials
Jones, A. P., Gamble, C., Clarke, M., & Williamson, P. R. (2011). The use of systematic reviews in the design of randomised trials [Undetermined]. doi:10.1186/1745-6215-12-s1-a54
2010
Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis
Hickey, H. R., Jones, A. P., Lenney, W., Williamson, P. R., & Smyth, R. L. (2010). Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis. TRIALS, 11. doi:10.1186/1745-6215-11-11
Dornase alfa for cystic fibrosis.
Jones, A. P., & Wallis, C. (2010). Dornase alfa for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127.pub2
2009
Erratum
Erratum (2009). Clinical Trials, 6(3), 288. doi:10.1177/1740774509339555
Does deworming improve growth and school performance in children?
Taylor-Robinson, D., Jones, A., & Garner, P. (2009). Does deworming improve growth and school performance in children?. PLoS neglected tropical diseases, 3(1), e358. doi:10.1371/journal.pntd.0000358
Does Deworming Improve Growth and School Performance in Children?
Taylor-Robinson, D., Jones, A., & Garner, P. (2009). Does Deworming Improve Growth and School Performance in Children?. PLoS Neglected Tropical Diseases, 3(1), e358. doi:10.1371/journal.pntd.0000358
Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials
Jones, A. P., Riley, R. D., Williamson, P. R., & Whitehead, A. (2009). Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. CLINICAL TRIALS, 6(1), 16-27. doi:10.1177/1740774508100984
2008
Can Western developmental screening tools be modified for use in a rural Malawian setting?
Gladstone, M. J., Lancaster, G. A., Jones, A. P., Maleta, K., Mtitimila, E., Ashorn, P., & Smyth, R. L. (2008). Can Western developmental screening tools be modified for use in a rural Malawian setting?. ARCHIVES OF DISEASE IN CHILDHOOD, 93(1), 23-29. doi:10.1136/adc.2006.095471
2007
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Unknown Journal, 1-158.
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 11(28), 1-iv. doi:10.3310/hta11280
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance. Cochrane Database of Sytematic reviews, (1).
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance.
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance.. The Cochrane database of systematic reviews, (4), CD000371. doi:10.1002/14651858.cd000371.pub3
Interventions for helping people recognise early signs of recurrence in bipolar disorder
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Interventions for helping people recognise early signs of recurrence in bipolar disorder. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD004854.pub2
Non-invasive ventilation for cystic fibrosis.
Moran, F., Bradley, J. M., Jones, A. P., & Piper, A. J. (2007). Non-invasive ventilation for cystic fibrosis.. The Cochrane database of systematic reviews, (4), CD002769. doi:10.1002/14651858.cd002769.pub2
Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder. Evidence-Based Mental Health, 10, 110.
2006
Penetration Testing Professional Ethics: a conceptual model and taxonomy
Pierce, J., Jones, A., & Warren, M. (2006). Penetration Testing Professional Ethics: a conceptual model and taxonomy. Australasian Journal of Information Systems, 13(2). doi:10.3127/ajis.v13i2.52
2005
A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis
Carrol, E. D., Thomson, A. P. J., Jones, A. P., Jeffers, G., & Hart, C. A. (2005). A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. INTENSIVE CARE MEDICINE, 31(10), 1415-1419. doi:10.1007/s00134-005-2787-x
Nebulised hypertonic saline for cystic fibrosis.
Wark, P. A. B., McDonald, V., & Jones, A. P. (2005). Nebulised hypertonic saline for cystic fibrosis.. In Unknown Book (pp. CD001506). doi:10.1002/14651858.cd001506.pub2
Once-daily netilmicin for neutropenic pyrexia in paediatric oncology
Hemsworth, S., Nunn, A., Selwood, K., Osborne, C., Jones, A., & Pizer, B. (2005). Once-daily netilmicin for neutropenic pyrexia in paediatric oncology. Acta Paediatrica, 94(3), 268-274. doi:10.1080/08035250510025923
Once-daily netilmicin for neutropenic pyrexia in paediatric oncology.
Hemsworth, S., Nunn, A. J., Selwood, K., Osborne, C., Jones, A., & Pizer, B. (2005). Once-daily netilmicin for neutropenic pyrexia in paediatric oncology.. Acta paediatrica (Oslo, Norway : 1992), 94(3), 268-274. doi:10.1111/j.1651-2227.2005.tb03068.x
High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews
Jones, A. P., Remmington, T., Williamson, P. R., Ashby, D., & Smyth, R. L. (2005). High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews. JOURNAL OF CLINICAL EPIDEMIOLOGY, 58(7), 741-742. doi:10.1016/j.jclinepi.2004.11.024
2004
Treatment of acute wheezing episodes in young children.
Smyth, R. L., & Jones, A. (2004). Treatment of acute wheezing episodes in young children.. The Journal of pediatrics, 145(2), 151-152. doi:10.1016/j.jpeds.2004.05.029
Interventions for helping people recognise early signs of recurrence in bipolar disorder
Morriss, R. M., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2004). Interventions for helping people recognise early signs of recurrence in bipolar disorder. In R. Morriss (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd004854
Interventions for helping people recognise early signs of recurrence in depression
Morriss, R., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2004). Interventions for helping people recognise early signs of recurrence in depression. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD004855
2003
Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng, S. M., & Jones, A. P. (2003). Drug therapies for reducing gastric acidity in people with cystic fibrosis.. The Cochrane database of systematic reviews, (2), CD003424. doi:10.1002/14651858.cd003424
Recombinant human deoxyribonuclease for cystic fibrosis.
Jones, A. P., & Wallis, C. E. (2003). Recombinant human deoxyribonuclease for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127
2001
Hydroxyurea for sickle cell disease.
Davies, S., & Olujohungbe, A. (2001). Hydroxyurea for sickle cell disease.. In Unknown Book (pp. CD002202). doi:10.1002/14651858.cd002202
Small world, big challenges: a report from the 9th International Congress of the World Federation of Public Health Associations.
Des Jarlais, D. C., & Jones, A. (2001). Small world, big challenges: a report from the 9th International Congress of the World Federation of Public Health Associations.. American journal of public health, 91(1), 14-15. doi:10.2105/ajph.91.1.14